Structure–activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor
✍ Scribed by Amy S. Antipas; Laura C. Blumberg; William H. Brissette; Matthew F. Brown; Jeffrey M. Casavant; Jonathan L. Doty; James Driscoll; Thomas M. Harris; Christopher S. Jones; Sandra P. McCurdy; Eric McElroy; Mark Mitton-Fry; Michael J. Munchhof; David A. Reim; Lawrence A. Reiter; Sharon L. Ripp; Andrei Shavnya; Marc I. Smeets; Kristen A. Trevena
- Book ID
- 104004468
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 231 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Novel indole-3-heterocycles were designed and synthesized and found to be potent CB1 receptor agonists. Starting from a microsomally unstable lead 1, a bioisostere approach replacing a piperazine amide was undertaken. This was found to be a good strategy for improving stability both in vitro and in